S-4/A - Akari Therapeutics Plc (0001541157) (Filer)

1 min to read

S-4/A – Akari Therapeutics Plc (0001541157) (Filer)

Filed: 2024-09-30 AccNo: 0001193125-24-228130 Size: 28 MB
Source: S-4/A – Akari Therapeutics Plc (0001541157) (Filer)

Diving Into Delaware’s Enforcement of Specific Performance in M&A Transactions

Most M&A agreements include specific performance provisions that allow either party, under certain circumstances, to seek to have a court...
Cohen Circle Acquisition Corp. I Announces Pricing of $200,000,000 Initial Public Offering

PHILADELPHIA, PA, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Cohen Circle Acquisition Corp. I (NASDAQ:CCIRU) (the “Company”) today announced the pricing...
S-4 – Gamma Acquisition HoldCo, L.L.C. (0002040272) (Filer)

Filed: 2024-10-11 AccNo: 0001104659-24-107823 Size: 3 MB Source: S-4 - Gamma Acquisition HoldCo, L.L.C. (0002040272) (Filer)
S-4 – Rafael Holdings, Inc. (0001713863) (Filer)

Filed: 2024-10-09 AccNo: 0001213900-24-086418 Size: 9 MB Source: S-4 - Rafael Holdings, Inc. (0001713863) (Filer)
SEC Testifies Before Congress & Updates from the Division of Corporation Finance

The Chair and Commissioners of the Securities and Exchange Commission testified before the US House of Representatives Committee on Financial...